AKT1 and rheumatoid arthritis: Artemisitene (ATT) also warrants consideration, as it has demonstrated pronounced reduction in the proliferation and induction of apoptosis in RA-FLSs through suppression of the PI3K/AKT axis and m6A regulation [46].